Search For "zydus"
Zydus' vaccine for COVID-19 completes pre-clinical development, to initiat
Updated : 5 years, 10 months ago IST
Ahmedabad (Gujarat) [India], July 3 (ANI): Healthcare major Zydus Cadila said on Friday its plasmid DNA vaccine candidate for COVID-19 (ZyCoV-D) developed indigenously at its vaccine technology centre here has successfully completed the pre-clinical phase.
Read More
DCGI permits human clinical trials for COVID-19 vaccine of Zydus Cadila
Updated : 5 years, 10 months ago IST
New Delhi [India], July 3 (ANI): The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI.
Read More
Zydus signs licensing agreement with Gilead to manufacture and market Remd
Updated : 5 years, 11 months ago IST
Ahmedabad (Gujarat) [India], June 13 (ANI): Healthcare major Zydus Cadila has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and distribution of Remdesivir, the investigational drug which has been issued an emergency use authorisation by the US Food
Read More
Zydus supplies first batch of 30,000 Covid Kavach Elisa tests to ICMR
Updated : 6 years ago IST
Ahmedabad (Gujarat) [India], May 21 (ANI): The first batch of 30,000 Covid Kavach Elisa tests manufactured by Zydus Diagnostics has been supplied to Indian Council of Medical Research (ICMR) free of cost.
Read More
Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical t
Updated : 6 years ago IST
New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila, the leading global pharmaceutical company in India, to conduct clinical trial using antiviral drug 'Pegylated Interferon Alpha-2b' in adul
Read More
Zydus explores biologicals route to treat COVID-19 with long-acting Interf
Updated : 6 years, 1 month ago IST
Ahmedabad (Gujarat) [India], April 20 (ANI): Pharma major Zydus Cadila said on Monday its biological therapy Pegylated Interferon alpha-2b can emerge as one of the pathways to treat COVID-19.
Read More
Avoid intake of 'hydroxychloroquine' without approval from doctor, says AI
Updated : 6 years, 1 month ago IST
New Delhi [India], April 12 (ANI): AIIMS Director Dr Randeep Guleria on Sunday warned the general public against the use of hydroxychloroquine, an anti-malarial drug deemed to be useful in dealing with COVID-19, without proper approval from doctors, stating that it can be harmful leading
Read More
Pharmaceutical industry produces 20 cr hydroxychloroquine tablets this mon
Updated : 6 years, 1 month ago IST
Ahmedabad (Gujarat) [India], April 11 (ANI): With the surge in demand for hydroxychloroquine, an anti-malarial drug deemed to be useful in dealing with COVID-19, the pharmaceutical industry has produced 20 crore HCQ tablets this month, said Pankaj Patel, CEO of Zydus Cadila in Ahmedabad, on
Read More
Zydus announces world's first drug for treatment of NASH
Updated : 6 years, 2 months ago IST
Ahmedabad (Gujarat) [India], Mar 5 (ANI): Global pharmaceutical company Zydus Cadila, on Thursday announced that the Drug Controller General of India (DCGI) has approved its new drug application (NDA) for Saroglitazar, a medicine for the treatment of a liver disease called Non-Cirrhotic Non-
Read More
Cadila Healthcare board approves merger of four subsidiaries to consolidat
Updated : 6 years, 5 months ago IST
Gandhinagar (Gujarat) [India], Dec 2 (ANI): The board of directors at Cadila Healthcare on Monday approved the amalgamation of Zydus Technologies Ltd (ZTL), Alidac Pharmaceuticals Ltd (APL), Liva Pharmaceuticals Ltd (LPL) and Dialforhealth India Ltd (DHIL) with Cadila Healthcare Ltd (CHL).
Read More
Zydus Cadila registers total income of Rs 3,496 crore, up 21 pc in Q1
Updated : 6 years, 9 months ago IST
Ahmedabad (Gujarat) [India], Aug 9 (ANI): Pharmaceuticals major Zydus Cadila on Friday reported total income from operations of Rs 3,496 crore in the first quarter ended June 30, up by 21 per cent on a year-on-year basis.
Read More
Columbia Asia Hospital thanks stakeholders before exiting its Ahmedabad op
Updated : 7 years, 6 months ago IST
New Delhi [India], Oct 30 (NewsVoir): Columbia Asia Hospital Pvt. Ltd. (Columbia Asia) has decided to close its operations of Ahmedabad unit.
Read More